title: Effects of dialysis and transplantation on red cell Na pump function in renal failure.
abstract: Ion pumping by the erythrocyte Na, K-ATPase has been measured using ouabain-sensitive 86Rb flux in 11 non-dialysed patients with chronic renal failure (CRF), 13 patients on haemodialysis (HD), 13 patients on peritoneal dialysis (CAPD) and 15 patients with functional transplants (FT). Flux measurements were performed in plasma and simultaneous estimates of specific 3H-ouabain binding were made. The results indicate that, compared to normal controls, Na,K pump flux was reduced by 21% in CRF (p less than 0.01), 30% in HD (p less than 0.01), 15% in CAPD (p less than 0.02), and was normal in FT. Mean specific ouabain binding sites per cell (+/- SEM) were; controls 366 +/- 16; CRF, 290 +/- 16; HD, 344 +/- 17; CAPD, 321 +/- 18; FT, 345 +/- 26. Calculation of mean turnover rate per pump site indicated that patients on HD showed a 30% reduction compared to controls (influx 55 K ions/s versus 79 K ions/s, p less than 0.01). Cross-incubation experiments suggest that the lowered pump flux seen in the CRF and HD groups was due to plasma factors. This work shows that erythrocyte Na,K pump number is reduced in CRF, while patients on maintenance HD have normal pump numbers per erythrocyte but reduced pump turnover.
authors.affiliation: Renal Unit, Churchill Hospital, Oxford, UK.
authors.forename: F C
authors.initials: FC
authors.lastname: Fervenza
authors.forename: B M
authors.initials: BM
authors.lastname: Hendry
authors.forename: J C
authors.initials: JC
authors.lastname: Ellory
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D001692:Biological Transport; D002462:Cell Membrane / Q000502:physiology; D004912:Erythrocytes / Q000378:metabolism / Q000502:physiology*; D006801:Humans; D007668:Kidney / Q000473:pathology / Q000502:physiology / Q000503:physiopathology; D007676:Kidney Failure, Chronic / Q000503:physiopathology*; D016030:Kidney Transplantation / Q000009:adverse effects*; D008875:Middle Aged; D010042:Ouabain / Q000378:metabolism; D010530:Peritoneal Dialysis; D011188:Potassium / Q000378:metabolism / Q000493:pharmacokinetics; D006435:Renal Dialysis / Q000009:adverse effects*; D000254:Sodium-Potassium-Exchanging ATPase / Q000378:metabolism*
chemical_list: D010042:Ouabain; D000254:Sodium-Potassium-Exchanging ATPase; D011188:Potassium